Optimizing adjuvant treatment strategies for non-pancreatic periampullary cancers.

Messaoudi, Nouredin; Vanlander, Aude; Gumbs, Andrew A

Messaoudi, Nouredin; Vanlander, Aude; Gumbs, Andrew A.

Afiliação

Messaoudi N; Department of Hepatopancreatobiliary Surgery, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) and Europe Hospitals, Brussels, Belgium.
Vanlander A; Department of Hepatopancreatobiliary Surgery, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) and Europe Hospitals, Brussels, Belgium.
Gumbs AA; Department of General-, Visceral-, Vascular- and Transplantation Surgery, University of Magdeburg, Magdeburg, Germany. aagumbs@gmail.com.

Br J Cancer ; 131(4): 617-618, 2024 Sep.

Article em En | MEDLINE | ID: mdl-39085361

ABSTRACT

ABSTRACT

Non-pancreatic periampullary tumors have long been neglected, leading to blurred adjuvant treatment strategies. Recent research, like the ISGACA group's study, is uncovering nuances in chemotherapy efficacy for these diverse cancers. Tailored approaches show promise, with artificial intelligence (AI) aiding in personalized treatment plans.

Assuntos

Inteligência Artificial; Humanos; Quimioterapia Adjuvante/métodos; Neoplasias do Ducto Colédoco/tratamento farmacológico; Neoplasias do Ducto Colédoco/patologia; Ampola Hepatopancreática/patologia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google